OC-033 Is Lymphocytic Duodenosis a Marker for Irritable Bowel Syndrome?
نویسندگان
چکیده
منابع مشابه
Diets and Irritable Bowel Syndrome
Introduction: Irritable bowel syndrome (IBS) is the most common functional gastrointestinal disorder, which is characterized by the presence of abdominal pain or discomfort associated with altered bowel habits. This systematic review aimed to assess the nutritional factors (dietary patterns and food groups) associated with IBS. Methods: Articles were collected ...
متن کاملIs irritable bowel syndrome a dysbiotic bowel syndrome?
Peter Benno*, Ragnar Befrits, Elisabeth Norin, Arnold Berstad, Atti-La Dahlgren, Tore Midtvedt and Per M. Hellström Gastroenterology and Endoscopy Unit, Läkarhuset Hötorgscity, Stockholm, Sweden; Department of Microbiology, Tumorbiology and Cellbiology, Karolinska Institutet, Stockholm, Sweden; Unger-Vetlesens Institutt, Lovisenberg Diakonale Sykehus, Oslo, Norway; Division of International and...
متن کاملIs irritable bowel syndrome a low-grade inflammatory bowel disease?
Irritable Bowel Syndrome (IBS) is multifactorial in its etiology and heterogeneous in its clinical presentation and pathogenesis. It is recognized that inflammation plays an important role in symptom generation, at least in a subset of patients with IBS. Previous gastroenteritis has been identified as the most important risk factor for IBS, and several studies reported that a substantial propor...
متن کاملSOOTHING THE IRRITABLE BOWEL SYNDROME Soothing the Irritable Bowel Syndrome
of patient presentations at gastrointestinal clinics, and up to 50% or more of patients presenting with abdominal symptoms have no organic abnormality detected. The most common functional gastrointestinal conditions in Canada are irritable bowel syndrome (IBS), and functional dyspepsia or nonulcer dyspepsia (NUD). Other functional disorders may affect specific regions of the alimentary tract, s...
متن کاملRifaximin for Irritable Bowel Syndrome
The current treatments for irritable bowel syndrome (IBS) are suboptimal. The findings of previous studies of rifaximin treatment for IBS may have differed due to variations in study design. Our study aimed to determine the therapeutic and adverse effects of rifaximin treatment for IBS based on a meta-analysis of published randomized controlled trials (RCTs). We searched the MEDLINE, EMBASE, EB...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Gut
سال: 2013
ISSN: 0017-5749,1468-3288
DOI: 10.1136/gutjnl-2013-304907.033